MENU
AKBA
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.75
Change
-$0.10 (-5.41%)
Capitalization
465.72M
118 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AKBA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Akebia Therapeutics (AKBA) Earnings Date & Reports

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AKBA is expected to report earnings to rise ∞% to 0 cents per share on March 12

Akebia Therapeutics AKBA Stock Earnings Reports
Q4'25
Est.
$0.01
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.03
The last earnings report on November 10 showed earnings per share of 0 cents, beating the estimate of -3 cents. With 3.77M shares outstanding, the current market capitalization sits at 465.72M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AKBA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AKBA showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AKBA
A.I. Advisor
published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com